- Home
- EHC vs BAX Comparison
EHC vs BAX Comparison
Compare EHC & BAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EHC
- BAX
- Stock Information
- Founded
- EHC 1983
- BAX 1931
- Country
- EHC United States
- BAX United States
- Employees
- EHC N/A
- BAX N/A
- Industry
- EHC Hospital/Nursing Management
- BAX Medical/Dental Instruments
- Sector
- EHC Health Care
- BAX Health Care
- Exchange
- EHC Nasdaq
- BAX Nasdaq
- Market Cap
- EHC 12.4B
- BAX 11.3B
- IPO Year
- EHC 1986
- BAX N/A
- Fundamental
- Price
- EHC $118.47
- BAX $18.75
- Analyst Decision
- EHC Strong Buy
- BAX Hold
- Analyst Count
- EHC 8
- BAX 9
- Target Price
- EHC $140.63
- BAX $30.78
- AVG Volume (30 Days)
- EHC 637.7K
- BAX 5.4M
- Earning Date
- EHC 10-29-2025
- BAX 10-30-2025
- Dividend Yield
- EHC 0.60%
- BAX 3.03%
- EPS Growth
- EHC 27.87
- BAX N/A
- EPS
- EHC 5.29
- BAX N/A
- Revenue
- EHC $5,795,600,000.00
- BAX $10,887,000,000.00
- Revenue This Year
- EHC $11.57
- BAX $7.40
- Revenue Next Year
- EHC $8.79
- BAX $3.78
- P/E Ratio
- EHC $23.74
- BAX N/A
- Revenue Growth
- EHC 11.13
- BAX 3.60
- 52 Week Low
- EHC $87.85
- BAX $21.33
- 52 Week High
- EHC $127.99
- BAX $37.74
- Technical
- Relative Strength Index (RSI)
- EHC 33.47
- BAX 21.97
- Support Level
- EHC $125.09
- BAX $22.53
- Resistance Level
- EHC $127.64
- BAX $23.35
- Average True Range (ATR)
- EHC 2.76
- BAX 0.57
- MACD
- EHC -0.38
- BAX -0.22
- Stochastic Oscillator
- EHC 53.47
- BAX 6.37
About EHC Encompass Health Corporation
Encompass Health Corp provides post-acute healthcare services in the United States through a network of inpatient rehabilitation hospitals. Inpatient rehabilitation contributes the majority of the firm's revenue and provides specialized rehabilitative treatment through a network of inpatient hospitals. These hospitals are concentrated in the eastern half of the United States and Texas.
About BAX Baxter International Inc.
Baxter offers a variety of medical supplies and equipment to providers. From its legacy operations, Baxter sells injectable therapies for use in care settings, including IV pumps, administrative sets, and solutions; nutritional products; and surgical sealants and hemostatic agents. Baxter expanded its portfolio of hospital-focused offerings by acquiring Hillrom in late 2021, which added basic equipment like hospital beds, operating room equipment, and patient monitoring tools to the portfolio. Baxter also sold its kidney care tools in early 2025.